Previous close | 111.90 |
Open | 111.90 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 150.00 |
Expiry date | 2026-01-16 |
Day's range | 82.80 - 111.90 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and Abbott Laboratories (ABT), as well as a micro-cap stock Ark Restaurants Corp. (ARKR).
On May 16, 2024, Rainer Blair, President & CEO of Danaher Corp (NYSE:DHR), executed a sale of 9,005 shares of the company.
Danaher (DHR) gains from strength in academic and applied markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology unit is concerning.